Intended for healthcare professionals


Covid-19: UK approves Moderna vaccine to be given as two doses 28 days apart

BMJ 2021; 372 doi: (Published 11 January 2021) Cite this as: BMJ 2021;372:n74

Read our latest coverage of the coronavirus outbreak

  1. Elisabeth Mahase
  1. The BMJ

The UK has approved the Moderna covid-19 vaccine and ordered an additional 10 million doses—bringing the total up to 17 million doses to be delivered from spring.

Interim analysis of the Moderna phase III trial reported that the vaccine was 94.5% effective 14 days after the second dose.1 The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the vaccine as a two dose regime, with the second dose given 28 days after the first.2

This comes after the UK announced that previously approved vaccines—Oxford …

View Full Text